The ubiquitin ligase activity of E6AP is required for ubiquitination and degradation of pRB by NS5B, suggesting that oncoviruses may exploit similar ubiquitin components to degrade key tumour suppressors. The gene discussed is UBE3A; the disease is neoplasm.